Abstract Archives of the RSNA, 2012
SSJ01-01
Diagnostic Performance of Automated Breast US as a Replacement Tool of Hand-held Second-look US
Scientific Formal (Paper) Presentations
Presented on November 27, 2012
Presented as part of SSJ01: Breast Imaging (Ultrasound)
Woo Jung Choi MD, Presenter: Nothing to Disclose
Eun Young Chae, Abstract Co-Author: Nothing to Disclose
Hee Jung Shin MD, Abstract Co-Author: Nothing to Disclose
Hyun Ji Kim, Abstract Co-Author: Nothing to Disclose
Hyunkyung Yoo, Abstract Co-Author: Nothing to Disclose
Hak Hee Kim MD, Abstract Co-Author: Nothing to Disclose
Joo Hee Cha, Abstract Co-Author: Nothing to Disclose
To evaluate the diagnostic performance of automated US of the breast as a replacement tool of second-look US performed after breast MRI.
During five months, we evaluated 58 consecutive patients (mean age, 45 years; range, 30~ 62 years) with breast cancer, who had additional suspicious lesions detected on breast MRI. All patients underwent hand-held second-look US (HH-SLUS) and automated breast US (ABUS). Three breast radiologists reviewed the detectability, location, characteristics, and conspicuity of these lesions on ABUS. We also evaluated the interobserver variability and compared with the results of HH-SLUS. Kappa statistics and intraclass correlation coefficient (ICC) were used for statistical analysis.
There were 80 additional suspicious lesions identified by breast MRI. Among them, 14 lesions (14/80,17.5%) were not detected on HH-SLUS. Eight lesions (8/14, 57%) were detected on ABUS by at least 2 readers whereas the remaining 6 (43%) were not detected on ABUS. Among 66 lesions detected on HH-SLUS, only three lesions (3/80, 4%) were not detected on ABUS. ICCs for lesion location and size all exceeded 0.75, indicating high reliability. Substantial agreement was found for mass shape, orientation, margin, and BIRADS final assessments (k = 0.71, 0.72, 0.61, and 0.63, respectively).
ABUS could reliably detect the additional suspicious lesions identified by breast MRI. Therefore, ABUS could reduce the cost and time of HH-SLUS and it might be helpful to decide the biopsy guidance method (US-guided vs. MR-guided).
ABUS could play a role as a replacement tool of hand-held second-look US for evaluating the additional suspicious lesions identified by breast MRI.
Choi, W,
Chae, E,
Shin, H,
Kim, H,
Yoo, H,
Kim, H,
Cha, J,
Diagnostic Performance of Automated Breast US as a Replacement Tool of Hand-held Second-look US. Radiological Society of North America 2012 Scientific Assembly and Annual Meeting, November 25 - November 30, 2012 ,Chicago IL.
http://archive.rsna.org/2012/12034539.html